Namakshenas P, Crezee J, Tuynman J, Tanis P, Oei A, Kok H
Pharmaceutics. 2025; 17(2).
PMID: 40006522
PMC: 11859678.
DOI: 10.3390/pharmaceutics17020155.
Wang K, Geng S, Wang F, Fang B, Qian H, Li Y
J Nanobiotechnology. 2024; 22(1):793.
PMID: 39719646
PMC: 11667857.
DOI: 10.1186/s12951-024-03069-0.
Piranfar A, Moradi Kashkooli F, Zhan W, Bhandari A, Soltani M
Ann Biomed Eng. 2024; 53(3):562-577.
PMID: 39570494
DOI: 10.1007/s10439-024-03650-6.
Souri M, Elahi S, Moradi Kashkooli F, Kohandel M, Soltani M
NPJ Syst Biol Appl. 2024; 10(1):136.
PMID: 39567549
PMC: 11579323.
DOI: 10.1038/s41540-024-00467-w.
Sun M, Ma S, Tang G, Deng W, Peng Y, Yu S
Abdom Radiol (NY). 2024; .
PMID: 39511028
DOI: 10.1007/s00261-024-04681-2.
Identifying metabolic limitations in the tumor microenvironment.
Cognet G, Muir A
Sci Adv. 2024; 10(40):eadq7305.
PMID: 39356752
PMC: 11446263.
DOI: 10.1126/sciadv.adq7305.
Characterization of Indeterminate Breast Lesions Based on Pressure Estimates by Noninvasive 3D Contrast-Enhanced Ultrasound.
Nam K, Torkzaban M, Shames J, Liao L, Wessner C, Machado P
Ultrasound Med Biol. 2024; 50(12):1854-1860.
PMID: 39237425
PMC: 11490378.
DOI: 10.1016/j.ultrasmedbio.2024.08.010.
Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy.
Longobardi G, Moore T, Conte C, Ungaro F, Satchi-Fainaro R, Quaglia F
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024; 16(5):e1990.
PMID: 39217459
PMC: 11670051.
DOI: 10.1002/wnan.1990.
Modified C-type natriuretic peptide normalizes tumor vasculature, reinvigorates antitumor immunity, and improves solid tumor therapies.
Lu Z, Verginadis I, Kumazoe M, Castillo G, Yao Y, Guerra R
Sci Transl Med. 2024; 16(761):eadn0904.
PMID: 39167664
PMC: 11866103.
DOI: 10.1126/scitranslmed.adn0904.
Tumor Stroma Content Regulates Penetration and Efficacy of Tumor-targeting Bacteria.
Zhan Y, Burkel B, Leaman E, Ponik S, Behkam B
bioRxiv. 2024; .
PMID: 38585966
PMC: 10996712.
DOI: 10.1101/2024.03.29.587035.
Mathematical model of oxygen, nutrient, and drug transport in tuberculosis granulomas.
Datta M, Kennedy M, Siri S, Via L, Baish J, Xu L
PLoS Comput Biol. 2024; 20(2):e1011847.
PMID: 38335224
PMC: 10883541.
DOI: 10.1371/journal.pcbi.1011847.
Image-Based Modeling of Drug Delivery during Intraperitoneal Chemotherapy in a Heterogeneous Tumor Nodule.
Rezaeian M, Heidari H, Raahemifar K, Soltani M
Cancers (Basel). 2023; 15(20).
PMID: 37894436
PMC: 10604968.
DOI: 10.3390/cancers15205069.
Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors.
Kim J, Cho H, Lim D, Joo M, Kim K
Int J Mol Sci. 2023; 24(12).
PMID: 37373227
PMC: 10298311.
DOI: 10.3390/ijms241210082.
A perfused multi-well bioreactor platform to assess tumor organoid response to a chemotherapeutic gradient.
Wasson E, He W, Ahlquist J, Hynes W, Triplett M, Hinckley A
Front Bioeng Biotechnol. 2023; 11:1193430.
PMID: 37324446
PMC: 10264793.
DOI: 10.3389/fbioe.2023.1193430.
Advances in lipid-based carriers for cancer therapeutics: Liposomes, exosomes and hybrid exosomes.
Moholkar D, Kandimalla R, Gupta R, Aqil F
Cancer Lett. 2023; 565:216220.
PMID: 37209944
PMC: 10325927.
DOI: 10.1016/j.canlet.2023.216220.
Non-invasive imaging of interstitial fluid transport parameters in solid tumors in vivo.
Majumder S, Islam M, Righetti R
Sci Rep. 2023; 13(1):7132.
PMID: 37130836
PMC: 10154396.
DOI: 10.1038/s41598-023-33651-9.
Multimodal ultrasonography findings of extramammary granular cell tumors: Two case reports.
Zhu M, Xu H, Chen Y, Peng Y
Front Oncol. 2023; 13:1136770.
PMID: 37020870
PMC: 10067867.
DOI: 10.3389/fonc.2023.1136770.
Stochasticity and Drug Effects in Dynamical Model for Cancer Stem Cells.
Mori L, Ben Amar M
Cancers (Basel). 2023; 15(3).
PMID: 36765635
PMC: 9913339.
DOI: 10.3390/cancers15030677.
Hypoxia signaling in cancer: Implications for therapeutic interventions.
Zhuang Y, Liu K, He Q, Gu X, Jiang C, Wu J
MedComm (2020). 2023; 4(1):e203.
PMID: 36703877
PMC: 9870816.
DOI: 10.1002/mco2.203.
HPMA copolymer-collagen hybridizing peptide conjugates targeted to breast tumor extracellular matrix.
Subrahmanyam N, Yathavan B, Kessler J, Yu S, Ghandehari H
J Control Release. 2022; 353:278-288.
PMID: 36244509
PMC: 10799842.
DOI: 10.1016/j.jconrel.2022.10.017.